Are Hotel REITs Attractive Again?

Are Hotel REITs Attractive Again?

Many investors are playing the recovery trade, looking for those stocks and companies that are not yet out of the pandemic woods, but should see a substantial improvement in their business results as the economy continues to open. Hospitality and travel-related companies are popular stocks for this investment strategy. However, with the hospitality-related REITs, shares […]

Trade of the Week: RBLX

Trade of the Week: RBLX

While the meme stocks have been getting most of the headlines lately, Roblox (RBLX) continues to have very active options.  One day last week, around 140,000 options traded, with 70% of the activity on the call side.  That tends to be a bullish signal.  Several of the larger trades looked to be bullish as well, […]

One-Stock Retirement vs. Diversification

One-Stock Retirement vs. Diversification

One-stock retirement. Those three words can stop you in your tracks, right? Is it a scam? A gimmick? Is it just click-bait? Well, not exactly.  Over the years, several financial advisors floated this idea and once in a while it gets some traction.  The concept suggests that investing modestly in just one stock could be […]

Where I See a Potential 10% Upside Going Into the Summer

Where I See a Potential 10% Upside Going Into the Summer

Growth stocks have seen some momentum in the past couple weeks… but I believe that will be capped in the short-term.  I’m actually looking at another opportunity no one is really talking about.  An opportunity for a potential 10% upside.  As many large cap stocks (think Apple) cool off, another trade could see a breakout […]

53495778 - science, chemistry, biology, medicine and people concept - close up of young scientists with pipette and flasks making test or research in clinical laboratory over hydrogen chemical formula

BIIB Stock Price Spikes On New Alzheimer’s Therapy Approval

Biogen’s (BIIB) stock price pushed higher this week the U.S. FDA approved its therapy for Alzheimer’s disease.  According to CNBC, “The FDA’s decision was highly anticipated as U.S. regulatory approval would make aducanumab the first drug approved to slow cognitive decline in people living with the disease and the first new medicine for Alzheimer’s in […]

Honest Company (HNST) Remains Volatile Following Recent IPO

Honest Company (HNST) Remains Volatile Following Recent IPO

Honest Company (HNST), the consumer goods brand founded by actress Jessica Alba, is a recent initial public offering (IPO). HNST began trading in early May after the company sold 25.8 million shares at $16 each, raising roughly $413 million. In its first day of action, HNST’s stock opened at $21.22, with the high hitting $23.88 […]

Here’s Why FATE’s Stock Priced Popped

Here’s Why FATE’s Stock Priced Popped

FATE’s stock price was higher on Friday because Fate Therapeutics (FATE) highlighted positive interim data from its study of FT516 in combination with Rituximab for B-cell Lymphoma. “FT516 is the Company’s universal, off-the-shelf natural killer (NK) cell product candidate derived from a clonal master induced pluripotent stem cell (iPSC) line engineered with a novel high-affinity, […]